"Clinical trials, progression-speed differentiating features and swiftness ..."

Ying Hong Li et al. (2020)

> Home

Details and statistics

DOI: 10.1093/BIB/BBY130

access: open

type: Journal Article

metadata version: 2024-07-24

- view
  - electronic edition via DOI (open access)
  authority control:
- export record
  dblp key:
  - journals/bib/LiLHWFYYLHXJCZ20
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/bib/LiLHWFYYLHXJCZ20
Ying Hong Li, Xiao Xu Li, Jiajun Hong, Yunxia Wang, Jianbo Fu, Hong Yang, Chun Yan Yu, Feng Cheng Li, Jie Hu, Weiwei Xue, Yu Yang Jiang, Yuzong Chen, Feng Zhu:
Clinical trials, progression-speed differentiating features and swiftness rule of the innovative targets of first-in-class drugs. Briefings Bioinform. 21(2): 649-662 (2020)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.